[Treatment of hepatocellular carcinoma with tumor thrombus in the main portal branch--analysis of five cases showing regression of the tumor thrombus].
Twenty-five cases of hepatocellular carcinoma with tumor thrombus in the first branch or trunk of the portal vein were treated with one-shot chemotherapy or transcatheter arterial embolization (TAE). Five of them showed regression of the tumor thrombus and survived 14 months on average. In these five cases, residual liver function was maintained at a good level. It was revealed that TAE was effective not only for tumors but also for tumor thrombi. But in cases with such tumor thrombus, normal liver tissue would be damaged by TAE. Therefore, residual liver function seems to be the most significant factor in choosing therapy.
D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000379:methods*; D006801:Humans; D008099:Liver / Q000503:physiopathology; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011169:Portal Vein / Q000000981:diagnostic imaging; D011379:Prognosis; D011859:Radiography; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins